Related Experiment Videos
Yolk sac tumors and alpha-fetoprotein in first year of life
1Department of Surgery, Oregon Health Sciences University, Portland.
Insights
Serum alpha-fetoprotein (AFP) levels are naturally higher in infants. Understanding these normal pediatric ranges is crucial for accurately using AFP as a tumor marker in young patients.
Area of Science:
- Pediatric Oncology
- Biomarker Analysis
- Tumor Markers
Background:
- Serum alpha-fetoprotein (AFP) is a tumor marker.
- Elevated AFP levels can indicate malignancy.
- Normal AFP ranges vary by age.
Observation:
- A one-month-old boy presented with a yolk sac tumor.
- Post-surgery, his AFP levels remained mildly elevated for six months.
- Predicted AFP half-life suggested a faster decline.
Findings:
- A literature review confirmed normally elevated AFP in infants under eight months.
- The patient's AFP levels were within the normal infant range within 60 days post-surgery.
- Persistent mild elevation was attributed to normal pediatric physiology, not residual tumor.
Implications:
- Accurate interpretation of AFP levels in infants requires age-specific reference ranges.
- Knowledge of normal infant AFP levels enhances diagnostic utility.
- This improves the clinical management of pediatric yolk sac tumors.
Abstract:
Serum alpha-fetoprotein (AFP) levels are normally elevated in the first eight months of life. This is important information when using AFP as a tumor marker for patients in this age group. We report a case of a one-month-old boy with a yolk sac tumor of the testis. After radical orchiectomy and a negative workup for metastatic disease, his AFP level dropped, but remained mildly elevated over the normal range for six months. Using a half-life of five days it was predicted that it would fall into this range in eighty days. Although the elevated levels suggested residual tumor, they did continue to decline each month which led us to pursue some other explanation for this pattern. A literature search revealed the AFP levels are normally elevated in this age group. In retrospect, our patient's AFP was within this range less than sixty days after surgery. Dissemination of knowledge that the normal AFP ranges in young infants are higher than those in older patients will improve the clinical usefulness of AFP as a tumor marker in this age group.